Explorer les evidences

4,54 relative_riskMaternal non-disclosure of HIV status to partner(s) was associated with a relative risk of 4.54 for infant HIV positivity at 12 months.

KenyaVIH/sidaobservé 12 monthspublié 2023European Journal of Public HealthOpenAlexdocument de 7 observationsDOI 10.1093/eurpub/ckad160.824

2 %Type 2 diabetes prevalence was 2.0% among males.

Kenyadiabète de type 2observé 2015publié 2020The Pan African medical journalPubMeddocument de 26 observations

7 218 childrenThe estimated sample size for parasite prevalence in the 2015 Kenya Malaria Indicator Survey (MIS) was 7218 children aged 0–4 years.

Kenyapaludismeobservé 2015publié 2017Malaria journaleurope_pmcdocument de 4 observations

Concomitant bacterial infections occur more frequently in children with severe malaria and are associated with mortality in children.

Kenyapaludismepublié 2004Journal of postgraduate medicineeurope_pmcdocument de 8 observations

0,36 odds_ratioCompared to patients with luminal A tumors, HER2-enriched patients had an odds ratio of 0.36 for obesity, with 95% confidence interval (0.16, 0.81) and p = 0.013.

Kenyacancer du seinobservé between March 2012 to May 2015publié 2021Breast cancer research : BCRPubMeddocument de 9 observations

80 %The mean proportion of participants with virological suppression at 2 years was 80% for participants in control clinics.

KenyaVIH/sidapublié 2023The lancet. HIVPubMeddocument de 8 observations

58,8 %Fifty-seven (58.8%) of the patients had moderate disease score.

KenyaRheumatoid Arthritis (RA)observé September 2011 – March 2012publié 2015University of Nairobi Research Archive (University of Nairobi)OpenAlexdocument de 10 observations

19 %The prevalence of pathogenic E. coli among patients seeking treatment for diarrheal illness at Kitale County Referral Hospital was 19% (56/295).

Kenyapathogenic E. colipublié 2017African Journal of Health SciencesOpenAlexdocument de 7 observations

0,4 RRCompared to unscreened houses, significantly fewer female Anopheles funestus were collected in screened houses, with a relative risk of 0.40 (95% CI 0.29–0.55).

Kenyapaludismepublié 2022Malaria journalPubMeddocument de 9 observations

62 %Overall, 62% of vaccine recipients in the rAd5 alone group responded to the HIV-1 proteins by an interferon-gamma (IFN-γ) ELISPOT.

KenyaVIH/sidapublié 2010PloS oneeurope_pmcdocument de 4 observations

-0,04 percentage_pointsThe difference in percentage of participants meeting the primary end point between the dolutegravir and ritonavir-boosted PI groups was -0.04 percentage points at week 48.

KenyaVIH/sidaobservé week 48publié 2023The New England journal of medicinePubMeddocument de 8 observations

11 %Among children living with HIV who were active on treatment, those who aged out of childhood ranged between 11% and 13%.

KenyaVIH/sidapublié 2025The Pediatric infectious disease journalPubMeddocument de 10 observations

17,4 %Normocytic hypochromic anemia occurred in 17.4% of HIV+TB+ injection substance users.

KenyaHIV and Mycobacterium tuberculosis co-infection · normocytic hypochromic anemiapublié 2020Ethiopian journal of health sciencesPubMeddocument de 6 observations

0,33 incidence_rate_ratioAlpha+-thalassaemia is associated with a reduced incidence of severe malaria, with an incidence rate ratio of 0.33 (95% CI: 0.15–0.73; p = 0.006) for heterozygotes and homozygotes combined compared to normal children.

Kenyaalpha+-thalassaemia · paludismepublié 2006PLoS medicineeurope_pmcdocument de 2 observations

2,76 aORUsing opioid agonist therapy was associated with increased ART coverage among people living with HIV (adjusted odds ratio = 2.76; 95% CI: 1.50–5.06).

KenyaVIH/sidapublié 2025The International journal on drug policyPubMeddocument de 10 observations

18 individualsAmong 348 women in a 2-year study of young women at high HIV risk in Thika and Kisumu, Kenya, 18 (5%) followed a steady high PrEP adherence trajectory.

KenyaVIH/sidapublié 2023AIDS and behaviorPubMeddocument de 5 observations

4,5 %HIV prevalence was 4.5% among adolescent girls and young women aged 15–24 years in western Kenya in 2018.

KenyaVIH/sidaobservé 2018publié 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 4 observations

81,9 %At 3 years, child HIV-free survival was 81.9% overall, 92.0% for children of women retained in care (RW), and 58.6% for children of women lost to follow-up (LW).

KenyaVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 13 observations

27 %Among 2340 contacts listed for 577 cases in Kenya, 632 contacts (27.0%) were traced.

KenyaCOVID-19publié 2022Journal of global healthPubMeddocument de 24 observations

0,4 %Among HIV-positive tuberculosis patients in Western Kenya, INH + ETO polyresistant strains occurred in 0.4% of cases.

Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 23 observations

1,8 relative_riskCompared with the $0 arm, caregivers in the $10.00 arm had significantly higher uptake of child HIV testing, with a relative risk of 1.80 (95% CI 1.15–2.80), P = 0.010.

KenyaVIH/sidapublié 2021AIDS (London, England)PubMeddocument de 3 observations

64 %Sixty-four percent of HIV-1-negative volunteers were positive for Plasmodium 18S, corresponding to 998 out of 1,569 individuals.

Kenyapaludisme · VIH/sidapublié 2021The American journal of tropical medicine and hygienePubMeddocument de 7 observations

9 %Of 16,903 children surveyed, 9% were febrile without Plasmodium falciparum infection.

Kenyapaludismeobservé 2007–2009publié 2010Malaria journaleurope_pmcdocument de 7 observationsDOI 10.1186/1475-2875-9-99

14 329 deathsContinuing pneumococcal conjugate vaccine (PCV) use in Kenya would prevent 14,329 deaths during the period following 2022.

Kenyapneumococcal diseasepublié 2019The Lancet. Global healtheurope_pmcdocument de 4 observations

5,3 %HBV prevalence was 5.3% (95% CI: 2.8–7.7%) among persons in the lowest wealth quintile in Kenya.

Kenyahépatite Bobservé 2018publié 2024PloS onePubMeddocument de 10 observations